Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Letter: Measurement of mild factor VIII inhibitors in Bethesda units.

Literature DB >> 1209554

Letter: Measurement of mild factor VIII inhibitors in Bethesda units.

C K Kasper, J G Pool.

Abstract

Mesh：

Substances：
Factor VIII

Year: 1975 PMID： 1209554

Source DB: PubMed Journal: Thromb Diath Haemorrh ISSN： 0340-5338

Keyword Cloud
Cited

× No keyword cloud information.

12 in total

1. Antigen-specific in vitro expansion of factor VIII-specific regulatory T cells induces tolerance in hemophilia A mice.

Authors: Bryn M Smith; Meghan J Lyle; Alex C Chen; Carol H Miao
Journal: J Thromb Haemost Date: 2019-10-29 Impact factor: 5.824

2. [Current aspects on evaluation of assays of factor-VIII activity, factor-VIII associated protein and factor-VIII neutralizing antibody (author's transl)].

Authors: G Hintz
Journal: Blut Date: 1978-02

3. Rare case of acquired haemophilia and lupus anticoagulant.

Authors: Devika Gupta; Tathagat Chatterjee; Ajay Sharma; Prosenjit Ganguli; Satyaranjan Das; Sanjeevan Sharma
Journal: Indian J Hematol Blood Transfus Date: 2012-10-09 Impact factor: 0.900

Review 4. Hemophilia A inhibitor treatment: the promise of engineered T-cell therapy.

Authors: Kalpana Parvathaneni; Maha Abdeladhim; Kathleen P Pratt; David W Scott
Journal: Transl Res Date: 2017-06-09 Impact factor: 7.012

5. Poor responder to plasma exchange therapy in acquired thrombotic thrombocytopenic purpura is associated with ADAMTS13 inhibitor boosting: visualization of an ADAMTS13 inhibitor complex and its proteolytic clearance from plasma.

Authors: Ayami Isonishi; Charles L Bennett; Barbara Plaimauer; Friedrich Scheiflinger; Masanori Matsumoto; Yoshihiro Fujimura
Journal: Transfusion Date: 2015-06-08 Impact factor: 3.157

Letter: Measurement of mild factor VIII inhibitors in Bethesda units.

1. Antigen-specific in vitro expansion of factor VIII-specific regulatory T cells induces tolerance in hemophilia A mice.

2. [Current aspects on evaluation of assays of factor-VIII activity, factor-VIII associated protein and factor-VIII neutralizing antibody (author's transl)].

3. Rare case of acquired haemophilia and lupus anticoagulant.

Review 4. Hemophilia A inhibitor treatment: the promise of engineered T-cell therapy.

5. Poor responder to plasma exchange therapy in acquired thrombotic thrombocytopenic purpura is associated with ADAMTS13 inhibitor boosting: visualization of an ADAMTS13 inhibitor complex and its proteolytic clearance from plasma.

6. Diagnostic and treatment guidelines for thrombotic thrombocytopenic purpura (TTP) 2017 in Japan.

7. Characterization of a monoclonal anti-idiotype antibody to human anti-factor VIII antibodies.

8. Covalent inactivation of factor VIII antibodies from hemophilia A patients by an electrophilic FVIII Analog.

9. [Different proportions of factor VIII and factor VIII inhibitors in their antigen-antibody complexes].

Review 10. Progress toward inducing immunologic tolerance to factor VIII.